BNP Paribas Arbitrage SA Has $23.22 Million Position in Clorox Company (The) (CLX)

BNP Paribas Arbitrage SA lifted its stake in shares of Clorox Company (The) (NYSE:CLX) by 21.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 176,044 shares of the company’s stock after buying an additional 31,178 shares during the period. BNP Paribas Arbitrage SA owned about 0.14% of Clorox Company (The) worth $23,222,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock. FMR LLC boosted its position in Clorox Company (The) by 8.3% in the first quarter. FMR LLC now owns 105,949 shares of the company’s stock worth $14,285,000 after purchasing an additional 8,088 shares during the last quarter. Renaissance Technologies LLC boosted its position in Clorox Company (The) by 11.8% in the first quarter. Renaissance Technologies LLC now owns 1,077,700 shares of the company’s stock worth $145,306,000 after purchasing an additional 113,700 shares during the last quarter. BlackRock Inc. boosted its position in Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock worth $1,400,912,000 after purchasing an additional 9,698,542 shares during the last quarter. KCG Holdings Inc. boosted its position in Clorox Company (The) by 108.5% in the first quarter. KCG Holdings Inc. now owns 9,048 shares of the company’s stock worth $1,220,000 after purchasing an additional 4,708 shares during the last quarter. Finally, Pinnacle Wealth Management Advisory Group LLC boosted its position in Clorox Company (The) by 5.9% in the first quarter. Pinnacle Wealth Management Advisory Group LLC now owns 2,525 shares of the company’s stock worth $340,000 after purchasing an additional 140 shares during the last quarter. 71.54% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “BNP Paribas Arbitrage SA Has $23.22 Million Position in Clorox Company (The) (CLX)” was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://stocknewstimes.com/2017/11/11/bnp-paribas-arbitrage-sa-has-23-22-million-position-in-clorox-company-the-clx.html.

In related news, SVP Jon M. Balousek sold 9,223 shares of the business’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the sale, the senior vice president now directly owns 20,614 shares in the company, valued at approximately $2,862,666.18. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Matthew T. Laszlo sold 20,051 shares of the business’s stock in a transaction on Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the sale, the senior vice president now owns 10,896 shares in the company, valued at $1,421,492.16. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 41,293 shares of company stock worth $5,560,303. 1.00% of the stock is currently owned by corporate insiders.

Clorox Company (NYSE:CLX) traded up $1.37 during trading hours on Friday, hitting $132.05. The company had a trading volume of 718,800 shares, compared to its average volume of 815,927. The company has a debt-to-equity ratio of 3.02, a quick ratio of 0.77 and a current ratio of 1.10. Clorox Company has a 12 month low of $111.77 and a 12 month high of $141.76. The company has a market cap of $16,849.70, a price-to-earnings ratio of 23.55, a price-to-earnings-growth ratio of 3.56 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings data on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The company had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.48 billion. During the same period in the previous year, the company posted $1.36 EPS. The firm’s revenue for the quarter was up 4.0% compared to the same quarter last year. sell-side analysts predict that Clorox Company will post 5.58 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 13th. Investors of record on Wednesday, October 25th will be paid a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, October 24th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.54%. Clorox Company (The)’s payout ratio is 61.88%.

CLX has been the topic of a number of recent research reports. Deutsche Bank AG reaffirmed a “hold” rating and set a $137.00 price target (up previously from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. BidaskClub cut Clorox Company (The) from a “sell” rating to a “strong sell” rating in a research report on Monday, July 24th. Zacks Investment Research cut Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Royal Bank Of Canada reaffirmed a “hold” rating and set a $115.00 price target on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Finally, BMO Capital Markets set a $150.00 price target on Clorox Company (The) and gave the company a “buy” rating in a research report on Thursday, August 3rd. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $128.72.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply